Anti-HER2 drugs for the treatment of advanced HER2 positive breast cancer
Last Updated: Friday, July 17, 2026
In this review article, authors discuss new treatment options for advanced HER2-positive breast cancer, including the most important findings from clinical trials and real-world reports, clinical benefits and risks of treatment, and efficacy of retreatment with trastuzumab in metastatic breast cancer.